...
首页> 外文期刊>Clinical and experimental hypertension: CEH >Related factors for worsening renal function following percutaneous transluminal renal angioplasty (PTRA) in patients with atherosclerotic renal artery stenosis
【24h】

Related factors for worsening renal function following percutaneous transluminal renal angioplasty (PTRA) in patients with atherosclerotic renal artery stenosis

机译:动脉粥样硬化性肾动脉狭窄患者经皮腔内肾血管成形术(PTRA)后肾功能恶化的相关因素

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF) after PTRA. Methods: We evaluated 92 patients with atherosclerotic renal artery stenosis (mean age 70.7 +/- 8.4 years). WRF was defined as a >= 0.3 mg/dL increase in creatinine levels after PTRA compared to before PTRA. Results: A total of 92 patients exhibited non-WRF 83 (90.2%), WRF 9 (9.8%). Significant differences were observed in serum creatinine levels between two groups both before (non-WRF 1.34 +/- 0.49 versus WRF 1.70 +/- 0.68 mg/dL, p = 0.0462) and after PTRA (non-WRF 1.31 +/- 0.43 versus WRF 2.42 +/- 1.12 mg/dL, p<0.0001). Patients with WRF had higher comorbidity rate of diabetes mellitus (DM) (non-WRF 31.3% versus WRF 66.7%, p = 0.0345) and proteinuria (non-WRF 27.7% versus WRF 66.7%, p = 0.0169), and had higher systolic blood pressure (non-WRF 143.6 +/- 18.7 versus WRF 157.1 +/- 19.9 mmHg, p = 0.0436), higher plasma B-type natriuretic peptide (BNP) levels, and larger left atrial and left ventricular end-diastolic dimensions before PTRA. Patients with WRF had a higher rate of taking diuretics (non-WRF 27.7% versus WRF 66.7%, p = 0.0169) after PTRA. Multiple logistic regression analysis revealed that comorbidity of DM was an independent related factor for WRF (comorbidity of DM, yes: OR 31.0, 95% CI 2.44-1024.62, p = 0.0055). Conclusions: Comorbidity of DM, coexisting of proteinuria, high creatinine level, high blood pressure, high BNP levels, and large left atrial and ventricular dimensions were related to WRF after PTRA in patients with atherosclerotic renal artery stenosis.
机译:目的:为了从保留肾功能的角度确定PTRA的候选人,我们在本文中评估了导致PTRA后肾功能恶化(WRF)的因素。方法:我们评估了92例患有动脉粥样硬化性肾动脉狭窄的患者(平均年龄70.7 +/- 8.4岁)。 WRF被定义为与PTRA前相比,PTRA后肌酐水平增加> = 0.3 mg / dL。结果:总共92例患者表现出非WRF 83(90.2%),WRF 9(9.8%)。在PTRA之前(非WRF 1.34 +/- 0.49与WRF 1.70 +/- 0.68 mg / dL,p = 0.0462)和PTRA后(两组,非WRF 1.31 +/- 0.43与vs),两组之间的血清肌酐水平存在显着差异。 WRF 2.42 +/- 1.12 mg / dL,p <0.0001)。患有WRF的患者合并糖尿病(DM)的合并症发生率较高(非WRF为31.3%相对于WRF 66.7%,p = 0.0345)和蛋白尿(非WRF为27.7%与WRF 66.7%,p = 0.0169),并且收缩期合并症较高血压(非WRF 143.6 +/- 18.7与WRF 157.1 +/- 19.9 mmHg,p = 0.0436),较高的血浆B型利钠肽(BNP)水平以及较大的左心房和左心室舒张末期尺寸。患有WRF的患者在PTRA后服用利尿剂的比例更高(非WRF为27.7%,而WRF为66.7%,p = 0.0169)。多元logistic回归分析显示,DM合并症是WRF的独立相关因素(DM合并症,是:OR 31.0,95%CI 2.44-1024.62,p = 0.0055)。结论:动脉粥样硬化性肾动脉狭窄患者行PTRA治疗后,WRF与DM合并症,蛋白尿并存,肌酐水平高,血压高,BNP水平高,左心房和室大有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号